Treatment of Arthritis With Syk Kinase Inhibition (TASKI-1)

NCT00326339 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

189

Enrollment

INDUSTRY

Sponsor class

Conditions

Rheumatoid Arthritis

Interventions

DRUG: R788
DRUG: Placebo

Sponsor

Rigel Pharmaceuticals